Pierre Fabre unveils its ALL project: the largest international dermatology database

Castres, June 20 , 2023 - On the occasion of the 25th World Congress of Dermatology (WCD), which will be held in Singapore from July 4 to 7, the Pierre Fabre Patient Relations Department will present the ALL project, a large-scale survey, the largest ever conducted in dermatology. 

This project, launched at the end of 2022, with the help of the company EMMA, aims to collect data on all skin types (ALL Skins), all skin diseases (ALL Dermatoses) and all phototypes (ALL Colors) in order to build the largest international private database .

50,552 people, from the adult populations of 20 countries (representing more than 50% of the world’s population) on five continents, answered the 65 ALL project questions.

The main themes discussed are related to the prevalence and the impact of medical conditions, but also the behaviors, care pathways and needs of patients affected by one or more dermatoses such as atopic dermatitis, psoriasis, acne, rosacea, and vitiligo (see complete list of subjects in Appendix 1).

The strength of this study lies in the considerable extent of the data collected and its representativeness: the respondents are drawn from samples proportional to the population of each country (sizes of samples per country in Appendix 2), enabling a very reliable analysis of needs on a global scale, by geographical territory. 

The 3.3 million data items thus compiled will identify the information essential to a better understanding of patient experiences. 

More than one in three people suffer from a skin disease, and yet health and prevention policies do not consider dermatology a public health priority. The ALL project aims to provide a global overview of the prevalence of the main skin diseases and their consequences in order to generate awareness among all stakeholders. Patients with dermatological diseases must receive more support and it is essential to convince the public authorities to give greater importance to dermatoses in prevention programs. 

This project, which is one of a kind, has already won the support of opinion leaders of international renown:  Prof. Jean Hilaire Saurat MD of the University of Geneva (acne), Prof. Gil Yosipovitch MD of the University of Miami (pruritus), Prof. Henry Lim MD of the University of Detroit and Prof. Khaled Ezzedine MD, dermatologist at the Paris Public Assistance Hospital (for photoprotection), Prof. Julien Seneschal MD, dermatologist at the Bordeaux University Hospital (vitiligo), and Prof. Marie Aleth Richard MD, dermatologist at the Marseille Public Assistance Hospital and former president of the French Society of Dermatology.

The ALL study data will also be shared with patient associations in order to help them make their case to the general public, health care professionals and the authorities. Seven patient associations have already contributed to this initiative in France and abroad.